This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 2018; 103: 356-87. doi: 10.1016/j.ejca.2018.07.005FerlayJColombetMSoerjomataramIDybaTRandiGBettioMet alCancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018Eur J Cancer20181033568710.1016/j.ejca.2018.07.00530100160Open DOISearch in Google Scholar
Wang F, Shu X, Meszoely I, Pal T, Mayer IA, Yu Z, et al. Overall mortality after diagnosis of breast cancer in men vs women. JAMA Oncol 2019. [Epub ahead of print]. doi: 10.1001/jamaoncol.2019.2803WangFShuXMeszoelyIPalTMayerIAYuZet alOverall mortality after diagnosis of breast cancer in men vs womenJAMA Oncol2019[Epub ahead of print]10.1001/jamaoncol.2019.2803675350331536134Open DOISearch in Google Scholar
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening-viewpoint of the IARC working group. N Engl J Med 2015; 372: 2353-8. doi: 10.1056/NEJMsr1504363Lauby-SecretanBScocciantiCLoomisDBenbrahim-TallaaLBouvardVBianchiniFet alBreast-cancer screening-viewpoint of the IARC working groupN Engl J Med20153722353810.1056/NEJMsr150436326039523Open DOISearch in Google Scholar
Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA - J Am Med Assoc 2015; 314: 1615-34. doi: 10.1001/jama.2015.13183MyersERMoormanPGierischJMHavrileskyLJGrimmLJGhateSet alBenefits and harms of breast cancer screening: a systematic reviewJAMA - J Am Med Assoc201531416153410.1001/jama.2015.1318326501537Open DOISearch in Google Scholar
Biganzoli L, Marotti L, Hart CD, Cataliotti L, Cutuli B, Kühn T, et al. Quality indicators in breast cancer care: an update from the EUSOMA working group. Eur J Cancer 2017; 86: 59-81. doi: 10.1016/j.ejca.2017.08.017BiganzoliLMarottiLHartCDCataliottiLCutuliBKühnTet alQuality indicators in breast cancer care: an update from the EUSOMA working groupEur J Cancer201786598110.1016/j.ejca.2017.08.01728963914Open DOISearch in Google Scholar
Rosselli Del Turco M, Ponti A, Bick U, Biganzoli L, Cserni G, Cutuli B, et al. Quality indicators in breast cancer care. Eur J Cancer 2010; 46: 2344-56. doi: 10.1016/j.ejca.2010.06.119RosselliDel Turco MPontiABickUBiganzoliLCserniGCutuliBet alQuality indicators in breast cancer careEur J Cancer20104623445610.1016/j.ejca.2010.06.11920675120Open DOISearch in Google Scholar
Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis [Internet]. Eur Guidel 2006 [cited 2020 Mar 30]. Available from: http://screening.iarc.fr/doc/ND7306954ENC_002.pdfPerryNBroedersMdeWolf CTornbergSHollandRvonKarsa LEuropean guidelines for quality assurance in breast cancer screening and diagnosis [Internet]Eur Guidel2006[cited 2020 Mar 30]. Available fromhttp://screening.iarc.fr/doc/ND7306954ENC_002.pdfSearch in Google Scholar
DORA programme colleagues. [Annual Report on the DORA Breast Cancer National Screening Program 2018]. [Slovenian]. [Internet]. Institute of Oncology Ljubljana - DORA National Breast Cancer Screening Programme 2019 [cited 2020 Mar 30]. Available from: https://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_letno_porocilo_2018_knjiznica.pdfDORA programme colleagues. [Annual Report on the DORA Breast Cancer National Screening Program 2018]. [Slovenian]. [Internet]. Institute of Oncology Ljubljana - DORA National Breast Cancer Screening Programme 2019 [cited 2020 Mar 30]Available fromhttps://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_letno_porocilo_2018_knjiznica.pdfSearch in Google Scholar
Cicero U, Rietjens M, Mahmoud ET, Virgilio S. Oncoplastic and reconstructive breast surgery Cham: Springer; 2019.CiceroURietjensMMahmoudETVirgilioSOncoplastic and reconstructive breast surgeryChamSpringer2019Search in Google Scholar
Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O’Regan R, Zelnak A, et al. Improving on national quality indicators of breast cancer care in a large public hospital as a means to decrease disparities for african american women. Ann Surg Oncol 2011; 18: 34-9. doi: 10.1245/s10434-010-1204-zRizzoMBumpersHOkoliJSenior-CrosbyDO’ReganRZelnakAet alImproving on national quality indicators of breast cancer care in a large public hospital as a means to decrease disparities for african american womenAnn Surg Oncol20111834910.1245/s10434-010-1204-z20625838Open DOISearch in Google Scholar
Wilcox N, McNeil JJ. Clinical quality registries have the potential to drive improvements in the appropriateness of care. Med J Aust 2016; 205: S27-9. doi: 10.5694/mja15.00921WilcoxNMcNeilJJClinical quality registries have the potential to drive improvements in the appropriateness of careMed J Aust2016205S27910.5694/mja15.0092127852198Open DOISearch in Google Scholar
Cheng SH, Wang CJ, Lin JL, Horng CF, Lu MC, Asch SM, et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care 2009; 47: 217-25. doi: 10.1097/MLR.0b013e3181893c4a.ChengSHWangCJLinJLHorngCFLuMCAschSMet alAdherence to quality indicators and survival in patients with breast cancerMed Care2009472172510.1097/MLR.0b013e3181893c4a19169123Open DOISearch in Google Scholar
Van Dam PA, Verheyden G, Sugihara A, Trinh XB, Van Der Mussele H, Wuyts H, et al. A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010. World J Surg Oncol 2013; 11: 70. doi: 10.1186/1477-7819-11-70VanDam PAVerheydenGSugiharaATrinhXBVanDer Mussele HWuytsHet alA dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010World J Surg Oncol2013117010.1186/1477-7819-11-70362391123497270Open DOISearch in Google Scholar
Plavc G, Ratoša I, Žagar T, Zadnik V. Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia. Breast Cancer Res Treat 2019; 175: 585-94. doi: 10.1007/s10549-019-05186-zPlavcGRatošaIŽagarTZadnikVExplaining variation in quality of breast cancer care and its impact: a nationwide population-based study from SloveniaBreast Cancer Res Treat20191755859410.1007/s10549-019-05186-z30847727Open DOISearch in Google Scholar
Henke G, Knauer M, Ribi K, Hayoz S, Gerard MA. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial. Trials 2018; 19: 667. doi: 10.1186/s13063-018-3021-9HenkeGKnauerMRibiKHayozSGerardMATailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trialTrials20181966710.1186/s13063-018-3021-9627813930514362Open DOISearch in Google Scholar
Ojala K, Meretoja TJ, Leidenius MHK. Aesthetic and functional outcome after breast conserving surgery - Comparison between conventional and oncoplastic resection. Eur J Surg Oncol 2017; 43: 658-64. doi:10.1016/j. ejso.2016.11.019OjalaKMeretojaTJLeideniusMHKAesthetic and functional outcome after breast conserving surgery - Comparison between conventional and oncoplastic resectionEur J Surg Oncol2017436586410.1016/j.ejso.2016.11.01928040314Open DOISearch in Google Scholar
Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles CE, et al. The requirements of a specialist breast centre. Breast 2020; 51: 65-84. doi: 10.1016/j.breast.2020.02.003BiganzoliLCardosoFBeishonMCameronDCataliottiLColesCEet alThe requirements of a specialist breast centreBreast202051658410.1016/j.breast.2020.02.003737568132217457Open DOISearch in Google Scholar
Van Dam PA, Tomatis M, Marotti L, Heil J, Mansel RE, Rosselli del Turco M, et al. Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres. Eur J Cancer 2017; 85: 15-22. doi: 10.1016/j. ejca.2017.07.040VanDam PATomatisMMarottiLHeilJManselRERossellidel Turco Met alTime trends (2006–2015) of quality indicators in EUSOMA-certified breast centresEur J Cancer201785152210.1016/j.ejca.2017.07.04028881247Open DOISearch in Google Scholar
Van Dam PA, Tomatis M, Marotti L, Heil J, Wilson R, Rosselli Del Turco M, et al. The effect of EUSOMA certification on quality of breast cancer care. Eur J Surg Oncol 2015; 41: 1423-9. doi: 10.1016/j.ejso.2015.06.006VanDam PATomatisMMarottiLHeilJWilsonRRosselliDel Turco Met alThe effect of EUSOMA certification on quality of breast cancer careEur J Surg Oncol2015411423910.1016/j.ejso.2015.06.00626278019Open DOISearch in Google Scholar
Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF. Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry. Int J Med Inform 2019; 125: 102-9. doi: 10.1016/j.ijmedinf.2019.03.004Hartmann-JohnsenOJKåresenRSchlichtingENaumeBNygårdJFUsing clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registryInt J Med Inform2019125102910.1016/j.ijmedinf.2019.03.00430914174Open DOISearch in Google Scholar
